News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,360 Results
Type
Article (40357)
Company Profile (307)
Press Release (652696)
Section
Business (206071)
Career Advice (1995)
Deals (35683)
Drug Delivery (87)
Drug Development (82125)
Employer Resources (168)
FDA (16245)
Job Trends (14956)
News (348434)
Policy (32699)
Tag
Academia (2570)
Alliances (49885)
Alzheimer's disease (1234)
Approvals (16175)
Artificial intelligence (134)
Bankruptcy (353)
Best Places to Work (11671)
Biotechnology (223)
Breast cancer (123)
Cancer (1138)
Cardiovascular disease (97)
Career advice (1664)
Cell therapy (244)
Clinical research (65297)
Collaboration (396)
Compensation (202)
COVID-19 (2542)
C-suite (99)
Data (1132)
Diabetes (152)
Diagnostics (6216)
Earnings (85370)
Employer resources (146)
Events (111329)
Executive appointments (313)
FDA (16791)
Funding (357)
Gene therapy (179)
GLP-1 (586)
Government (4354)
Healthcare (18908)
Infectious disease (2627)
Inflammatory bowel disease (108)
Interviews (308)
IPO (16431)
Job creations (3651)
Job search strategy (1421)
Layoffs (425)
Legal (7882)
Lung cancer (183)
Manufacturing (177)
Medical device (13225)
Medtech (13230)
Mergers & acquisitions (19334)
Metabolic disorders (405)
Neuroscience (1512)
NextGen Class of 2024 (6565)
Non-profit (4499)
Northern California (1488)
Obesity (235)
Opinion (185)
Patents (102)
People (56964)
Phase I (20343)
Phase II (28747)
Phase III (21454)
Pipeline (463)
Postmarket research (2585)
Preclinical (8622)
Radiopharmaceuticals (248)
Rare diseases (220)
Real estate (5950)
Regulatory (21748)
Research institute (2359)
Resumes & cover letters (349)
Southern California (1308)
Startups (3627)
United States (13616)
Vaccines (559)
Weight loss (171)
Date
Today (43)
Last 7 days (678)
Last 30 days (3640)
Last 365 days (36146)
2024 (33177)
2023 (40496)
2022 (51695)
2021 (56235)
2020 (54543)
2019 (47059)
2018 (35456)
2017 (32656)
2016 (32027)
2015 (38064)
2014 (31749)
2013 (26719)
2012 (28928)
2011 (29660)
2010 (27609)
Location
Africa (723)
Arizona (192)
Asia (37865)
Australia (6185)
California (3359)
Canada (1297)
China (257)
Colorado (147)
Connecticut (154)
Europe (82124)
Florida (461)
Georgia (116)
Illinois (345)
Indiana (196)
Kansas (97)
Maryland (582)
Massachusetts (2662)
Michigan (158)
Minnesota (276)
New Jersey (960)
New York (966)
North Carolina (709)
Northern California (1488)
Ohio (139)
Pennsylvania (850)
South America (1103)
Southern California (1308)
Texas (467)
Utah (90)
Washington State (363)
693,360 Results for "ilex oncology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OneCell Diagnostics, Inc. Announces Oversubscribed Series A Funding Round to Accelerate Proprietary Cell Biopsy Technology to Democratize Precision Oncology
November 21, 2024
·
4 min read
Press Releases
Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals
October 24, 2024
·
5 min read
Press Releases
Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR™ (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology
September 5, 2024
·
14 min read
Press Releases
Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid Tumors
November 11, 2024
·
18 min read
Press Releases
Xenetic Biosciences, Inc. Enters into Materials Transfer Agreement with Tokyo Medical University for the Advancement of Its DNase-Based Oncology Platform
October 18, 2024
·
6 min read
Press Releases
EnClear Therapies, Inc. Secures Additional Funding to Advance Neuro-Oncology Innovations
September 4, 2024
·
2 min read
Biotech Beach
Kura Oncology to Participate in Stifel Targeted Oncology Forum
Kura Oncology, Inc. today announced its participation in Stifel 2024 Targeted Oncology Forum.
April 10, 2024
·
2 min read
Press Releases
Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc.
August 13, 2024
·
9 min read
Press Releases
Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.
August 5, 2024
·
8 min read
Genetown
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 28, 2024
Pyxis Oncology, Inc., a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, reported that Pyxis Oncology’s Compensation Committee of the Board of Directors granted restricted stock units with respect to an aggregate of 89,530 shares of Pyxis Oncology’s common stock and stock options to purchase an aggregate of 111,913 shares of Pyxis Oncology’s common stock to five newly hired employees.
June 28, 2024
·
2 min read
1 of 69,336
Next
